(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MINORYX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MINORYX

ST13

US500000079179921

Class

5, 42, 44

Filing

79179921

Registration

5521544

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

65

Latest update

05/08/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

10/28/2015

Registration date

07/24/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/28/2025

Last transaction

05/08/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Mataró, ES

Examiner

ASKEW, MEGAN RUTH

Current location

Historical data usage

Holders and representatives

Holders

Minoryx Therapeutics, S.L.
Minoryx Therapeutics, S.L.

Representatives

Elizabeth Lee D'Amore Lucas & Mercanti LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparations for medical use; all of the foregoing excluding pharmaceutical and diagnostic products for dentistry use; all of the foregoing excluding dietary and nutritional supplements

Class 42

scientific and technological servicesscientific research in the field of rare diseases and research and design relating thereto; research and development services and drug discovery servicesall for new techniques for medical diagnosis and medicinesdesign and development of software relating thereto ; research and development services and drug discovery services in the field of human health care

Class 44

Medical services

Publications

History of USPTO decisions and trademark events.

65 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

05/07/2026

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/20/2026

INPC

INVALIDATION PROCESSED

03/20/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/09/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/09/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/09/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/09/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/28/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/11/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

01/28/2025

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

01/28/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/27/2025

ES71

TEAS SECTION 71 RECEIVED

07/24/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/24/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/30/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/09/2018

FIMP

FINAL DISPOSITION PROCESSED

11/09/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/24/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

07/24/2018

TMBN

TTAB RELEASE CASE TO TRADEMARKS

06/14/2018

OP.T

OPPOSITION TERMINATED NO. 999999

06/14/2018

OP.D

OPPOSITION DISMISSED NO. 999999

06/14/2018

EXPT

EXPARTE APPEAL TERMINATED

11/20/2017

RFNT

REFUSAL PROCESSED BY IB

11/17/2017

GPNX

NOTIFICATION PROCESSED BY IB

11/17/2017

OP.I

OPPOSITION INSTITUTED NO. 999999

10/30/2017

OPNS

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

10/25/2017

OPNC

OPPOSITION NOTICE (IB REFUSAL) CREATED

10/25/2017

OPPF

OPPOSITION PAPERS RECEIVED AT TTAB

10/24/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2017

PUBO

PUBLISHED FOR OPPOSITION

10/24/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/15/2017

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

09/06/2017

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/16/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/31/2017

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/31/2017

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

03/11/2017

GNSF

SUBSEQUENT FINAL EMAILED

03/11/2017

CFRC

SUBSEQUENT FINAL REFUSAL WRITTEN

03/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/08/2017

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

03/03/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/01/2017

EXPI

EX PARTE APPEAL-INSTITUTED

03/01/2017

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

03/01/2017

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

03/01/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/01/2016

GNFR

FINAL REFUSAL E-MAILED

09/01/2016

CNFR

FINAL REFUSAL WRITTEN

09/01/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/11/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/11/2016

ALIE

ASSIGNED TO LIE

08/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2016

RFNT

REFUSAL PROCESSED BY IB

03/11/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/22/2016

RFRR

REFUSAL PROCESSED BY MPU

02/22/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/21/2016

CNRT

NON-FINAL ACTION WRITTEN

02/20/2016

DOCK

ASSIGNED TO EXAMINER

02/20/2016

MAFR

APPLICATION FILING RECEIPT MAILED

01/09/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/05/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/03/2016

Continuous trademark protection

Get notified about every new filing that threatens MINORYX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.